Yoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, Daisuke Matsui, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, Toshiyuki Shimizu, Yuji Murase, Yutaro Shimamoto, et al. Predictors of continuation for asenapine from real-world data in patients with schizophrenia. Annals of general psychiatry. 2024. 23. 1. 29-29
Yoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, Daisuke Matsui, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, Toshiyuki Shimizu, Yuji Murase, Yosuke Koshikawa, et al. Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data. Neuropsychopharmacology reports. 2024. 44. 1. 234-239
Masaki Kato, Hajime Baba, Yoshiteru Takekita, Minami Naito, Yosuke Koshikawa, Hiroki Bandou, Toshihiko Kinoshita. Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study. European journal of clinical pharmacology. 2023. 79. 11. 1515-1524
Yosuke Koshikawa, Ai Onohara, Masataka Wakeno, Yoshiteru Takekita, Toshihiko Kinoshita, Masaki Kato. Characteristics of persistent depression in the long-term: Randomized controlled trial and two-year observational study. Heliyon. 2023. 9. 10. e20917
Atsuko Yamamoto, Banri Tsukuda, Shota Minami, Seina Hayamizu, Minami Naito, Yosuke Koshikawa, Toshiya Funatsuki, Chikashi Takano, Haruhiko Ogata, Yoshiteru Takekita, et al. Effectiveness and Changes in Brain Functions by an Occupational Therapy Program Incorporating Mindfulness in Outpatients with Anxiety and Depression: A Randomized Controlled Trial. Neuropsychobiology. 2023. 1-13